Anil Karihaloo Novo NordiskUnited States

Ph.D in neuroscience from PGIMER , Chandigarh, IndiaPostdoc at University of Michigan and Harvard medical school.Research faculty at Yale University School of Medicine until 2014Joined AstraZeneca in 2014 and Novo Nordisk in 2017 to lead early target discovery efforts in CKD

1 APRIL 2023

Time Session
15:45
16:45
Wenjun Ju Chairperson wenjunj@med.umich.eduUniversity Of Michigan Medical CenterUnited States
Maria F. Gomez Chairperson Sweden
  • Summary of Big Data and Open Science Pre-symposium
    Wenjun Ju Speaker wenjunj@med.umich.eduUniversity Of Michigan Medical CenterUnited States
  • Panel Discussion
    Anil Karihaloo Speaker Novo NordiskUnited States
    Darren Kelly Speaker Certa TherapeuticsAustralia
    Heather Ascani Speaker University of MichiganUnited States
    Jonathan Himmelfarb Speaker jhimmelfarb@nephrology.washington.eduKidney Research Institute, University of Washington United States
    Olga Troyanskaya Speaker Princeton UniversityUnited States
  • Moderated Free Communication with Panelists
  • Summary and Conclusion
    Maria F. Gomez Speaker Sweden
MR 109 CDHG